Sunday, 2 September 2001

PUBERTY AND ADOLESCENT MEDICINE

Chairs: G. Saggese (Italy) - J. Brämswig (Germany)

Mechanisms of puberty
M. Grumbach (United States)

Factors affecting onset of puberty
H. Delemarre van der Waal (The Netherlands)

Secular trends in pubertal development: worldwide experience
J. Karlberg (Sweden)

Chairs: M. Maes (Belgium) - J. Lebl (Czech Republic)

Pathogenesis of precocious puberty in hypothalamic hamartoma
H. Jung (Germany)

LH- and FSH receptor mutations
I. Huhtaniemi (Finland)

Chairs: M. Tauber (France) - M. Bozzola (Italy)

Puberty in children with cancer
S. Shalet (United Kingdom)

Environmental influences on development of male reproductive system
N. Skakkebaek (Denmark)

Chair: F. Waldhauser (Austria)

Novel treatment of delayed male puberty with aromatase inhibitors
L. Dunkel (Finland)

Puberty in chronic disease
D. Simon (France)

- in anorexia nervosa -- J. Argente (Spain)

- in coeliac disease -- G. Bona (Italy)

Monday, 3 September 2001

GROWTH AND GROWTH HORMONE

Chairs: J.M. Wit (The Netherlands) - T. Battelino (Slovenia)

New results from growth prediction models
B. Kristroem (Sweden) & K. Albertsson-Wikland (Sweden)

Effect of GH on pubertal growth in IUGR
A. Lienhardt (France)

Bisphosphonate therapy in osteogenesis imperfecta
S. Adami (Italy)

Chairs: J.C. Carel (France) – J. Gregory (United Kingdom)

Bisphosphonate therapy in McCune Albright Syndrome
E. Schönau (Germany)

Asthma and growth problems
Ole D. Wolthers (Denmark)

ADRENAL DISORDERS

Chairs: L. Ibanez (Spain)

Congenital adrenal hypoplasia: range of genetic causes
J.L. Chaussain (France)

New genetic aspects of ACTH resistance
A. Huebner (Germany)

CAH – lessons from a multinational study
H. Frisch (Austria)

Female hyperandrogenism: pathogenesis and treatment
P. Saenger (United States)